The selected model is an APP/(presenilin-1) PS1 double transgenic mouse that coexpresses five familial AD mutations (5XFAD) and exhibits an amyloid plaque pathology similar to that found in AD [37]. The gene discussed is PSEN1; the disease is Alzheimer disease.